|
Reliance Industries Limited
|
|
POLYPROPYLENE
|
| REPOL H350FG |
HOMOPOLYMER |
| |
| Product
description & applications : |
Features
: |
|
REPOL Polypropylene H350FG is manufactured using Unipol
PP process which combines the production efficiency
of gas phase fluidized bed reactor technology with the
high activity and stereo specificity of the SHAC catalyst
system.
REPOL H350FG is recommended for use incompact
spinning operations for making multifilament fine denier
multifilament yarn and nonwovens.
|
Repol
H350FG is designed to provide
- Good spinning characteristics
- Consistent processabillityat highl ine speeds
- Good colour stability
- Good flow behaviour
|
| |
| Typical properties
of Repol H350FG are as follows: |
| |
| Property |
ASTM Test
Method |
Unit |
Typical Value*. |
| Melt
flow index,(230oc/2.16Kg) |
D
1238 |
g/10
min |
35.0 |
| Tensile
Strength at yield (50 mm/min ) |
D
638$ |
MPa |
34 |
| Elongation
at yield (50 mm/min ) |
D
638$ |
% |
10 |
| Flexural
modulus (1% secant) |
D
790A$ |
MPa |
1650 |
| Notched
izod impact strength (23oc) |
D
256$ |
J/m |
22 |
| Heat
deflection temperature (455 kPa) |
D
648 |
oC |
104 |
| |
| |
|
$ : ASTM D638 Type I specimen injection moulded and
tested in accordance with ASTM D4101.
|
|
|
|
Repol H350FG meets the requirements stipulated in IS
10910-1984 on on "Specification for Polypropylene and
its copolymers for safe use in contact with foodstuffs,
pharmaceuticals, and drinking water". Additives incorporated
in this grade conform to the positive list of constituents
as prescribed in IS-10909-1984.The grade and the additives
incorporated in it also comply with the FDA:CFR Title
21, 177.1520, Olefin polymers.
|
|
|
|
REPOL is the registered trademark for Polypropylene
from Reliance Industries Limited
|
|
|
|
* Typical valuesw with injection moulded specimens,
not to be taken as specification
|
|
The data, information and suggestions contained contained
herein are given purely as a guide. Reliance Industries
Limited and Reliance Group Companies undertake no responsibility
either for the results deriving from their adoption
or for possible position in apparent contrast with existing
patent rights.
|